X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
52
PharmaCompass offers a list of Atropine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Atropine manufacturer or Atropine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Atropine manufacturer or Atropine supplier.
PharmaCompass also assists you with knowing the Atropine API Price utilized in the formulation of products. Atropine API Price is not always fixed or binding as the Atropine Price is obtained through a variety of data sources. The Atropine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Atropine Methyl Nitrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Atropine Methyl Nitrate, including repackagers and relabelers. The FDA regulates Atropine Methyl Nitrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Atropine Methyl Nitrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Atropine Methyl Nitrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Atropine Methyl Nitrate supplier is an individual or a company that provides Atropine Methyl Nitrate active pharmaceutical ingredient (API) or Atropine Methyl Nitrate finished formulations upon request. The Atropine Methyl Nitrate suppliers may include Atropine Methyl Nitrate API manufacturers, exporters, distributors and traders.
click here to find a list of Atropine Methyl Nitrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Atropine Methyl Nitrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Atropine Methyl Nitrate active pharmaceutical ingredient (API) in detail. Different forms of Atropine Methyl Nitrate DMFs exist exist since differing nations have different regulations, such as Atropine Methyl Nitrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Atropine Methyl Nitrate DMF submitted to regulatory agencies in the US is known as a USDMF. Atropine Methyl Nitrate USDMF includes data on Atropine Methyl Nitrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Atropine Methyl Nitrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Atropine Methyl Nitrate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Atropine Methyl Nitrate Drug Master File in Korea (Atropine Methyl Nitrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Atropine Methyl Nitrate. The MFDS reviews the Atropine Methyl Nitrate KDMF as part of the drug registration process and uses the information provided in the Atropine Methyl Nitrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Atropine Methyl Nitrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Atropine Methyl Nitrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Atropine Methyl Nitrate suppliers with KDMF on PharmaCompass.
A Atropine Methyl Nitrate CEP of the European Pharmacopoeia monograph is often referred to as a Atropine Methyl Nitrate Certificate of Suitability (COS). The purpose of a Atropine Methyl Nitrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Atropine Methyl Nitrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Atropine Methyl Nitrate to their clients by showing that a Atropine Methyl Nitrate CEP has been issued for it. The manufacturer submits a Atropine Methyl Nitrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Atropine Methyl Nitrate CEP holder for the record. Additionally, the data presented in the Atropine Methyl Nitrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Atropine Methyl Nitrate DMF.
A Atropine Methyl Nitrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Atropine Methyl Nitrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Atropine Methyl Nitrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Atropine Methyl Nitrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Atropine Methyl Nitrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Atropine Methyl Nitrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Atropine Methyl Nitrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Atropine Methyl Nitrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Atropine Methyl Nitrate suppliers with NDC on PharmaCompass.
Atropine Methyl Nitrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Atropine Methyl Nitrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Atropine Methyl Nitrate GMP manufacturer or Atropine Methyl Nitrate GMP API supplier for your needs.
A Atropine Methyl Nitrate CoA (Certificate of Analysis) is a formal document that attests to Atropine Methyl Nitrate's compliance with Atropine Methyl Nitrate specifications and serves as a tool for batch-level quality control.
Atropine Methyl Nitrate CoA mostly includes findings from lab analyses of a specific batch. For each Atropine Methyl Nitrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Atropine Methyl Nitrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Atropine Methyl Nitrate EP), Atropine Methyl Nitrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Atropine Methyl Nitrate USP).
Market Place
